Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

NCT06957366 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

920

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation (AF)
VTE

Interventions

OTHER: PAUSE Perioperative DOAC Management
OTHER: ASRA Perioperative DOAC Management

Sponsor

McMaster University